[Malondialdehyde-modified-low density lipoprotein in diabetes mellitus].
Malondialdehyde-modified-low density lipoprotein (MDA-LDL), lipid peroxide (LPO), lipid and fasting blood glucose (FBG) were studied in 42 diabetic patients and 20 age-matched controls. The results revealed that both MDA-LDL per L serum and MDA-LDL per mol LDL-C of diabetics were higher than those of controls. MDA-LDL/L tended to be much higher in diabetic patients with vascular disease and hyperlipidemia. There was a positive correlation between MDA-LDL/L and LPO, LDL-C, TC, respectively.
Tian
H
H
Liang
J
J
Zhang
X
X
D000328:Adult; D000368:Aged; D003920:Diabetes Mellitus / Q000097:blood*; D005260:Female; D006801:Humans; D008054:Lipid Peroxides / Q000097:blood; D008077:Lipoproteins, LDL / Q000097:blood*; D008297:Male; D008315:Malondialdehyde / Q000494:pharmacology; D008875:Middle Aged
D008054:Lipid Peroxides; D008077:Lipoproteins, LDL; D008315:Malondialdehyde